{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:31:00Z","timestamp":1791509460860,"version":"4.3.4"},"reference-count":24,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2018,4,8]],"date-time":"2018-04-08T00:00:00Z","timestamp":1523145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background and Objectives: Immunosuppressed individuals are at particularly increased risk for human papilloma virus-related infections. The primary objective of our study is to determine if there are any adverse effects associated with high-dose cimetidine treatment. A secondary objective is to report our experience with cimetidine in the treatment of cutaneous warts in pediatric heart transplant recipients. Methods and Results: This was a retrospective observational study. A total of 8 pediatric heart transplant recipients diagnosed with multiple recalcitrant warts were the subject of the study. All patients were treated with cimetidine (30\u201340 mg\/kg\/day) in two divided doses for 3 to 6 month durations. All patients had complete resolution of their lesions except 1 patient who had no clinical improvement. Of these 8 patients, one had recurrence of warts at one year follow-up, which resolved with restarting cimetidine therapy. One patient who had only 3 months of cimetidine therapy had immediate relapse after cimetidine was stopped. None of them had significant change in their tacrolimus trough, serum creatinine, and alanine transaminase levels. No adverse events were reported except one patient experienced mild gynecomastia. Conclusion: Cimetidine can be a safe and alternative treatment option for multiple warts in pediatric heart transplant recipients.<\/jats:p>","DOI":"10.3390\/medsci6020030","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T13:06:08Z","timestamp":1523365568000},"page":"30","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cimetidine: A Safe Treatment Option for Cutaneous Warts in Pediatric Heart Transplant Recipients"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-8785","authenticated-orcid":false,"given":"Bibhuti B","family":"Das","sequence":"first","affiliation":[{"name":"Joe DiMaggio Children\u2019s Hospital Heart Institute, Memorial Health Care, Hollywood, FL 33021, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5387-5503","authenticated-orcid":false,"given":"Kristin","family":"Anton","sequence":"additional","affiliation":[{"name":"Children\u2019s Health Heart Institute, Dallas, Texas 75235, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelia","family":"Soares","sequence":"additional","affiliation":[{"name":"Children\u2019s Health Heart Institute, Dallas, Texas 75235, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Riojas","sequence":"additional","affiliation":[{"name":"Children\u2019s Health Heart Institute, Dallas, Texas 75235, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Mcdermott","sequence":"additional","affiliation":[{"name":"Children\u2019s Health Heart Institute, Dallas, Texas 75235, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Knox","sequence":"additional","affiliation":[{"name":"Children\u2019s Health Heart Institute, Dallas, Texas 75235, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Daneman","sequence":"additional","affiliation":[{"name":"Children\u2019s Health Heart Institute, Dallas, Texas 75235, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao N","family":"Puente","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, UTSW Medical Center, Dallas, Texas 75235, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jcv.2012.07.014","article-title":"Cutaneous warts-associated HPV types: Prevalence and relation with patient characteristics","volume":"55","author":"Bruggink","year":"2012","journal-title":"J. Clin. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1440-0960.1996.tb01010.x","article-title":"The descriptive epidemiology of warts in the community","volume":"37","author":"Kilkenny","year":"1996","journal-title":"Aust. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1432-2277.2004.00069.x","article-title":"Skin disorders in patients transplanted in childhood","volume":"18","author":"Fortina","year":"2005","journal-title":"Transpl. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-4362.1991.tb04787.x","article-title":"Benign human papillomavirus infection in renal transplant recipients","volume":"30","author":"Trowell","year":"1991","journal-title":"Int. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2133.1977.tb14243.x","article-title":"Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus","volume":"97","author":"Viac","year":"1977","journal-title":"Br. J. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/514964","article-title":"The AMA Expert Panel on External Genital Warts. External Genital Warts: Report of the American Medical Association Consensus Conference","volume":"27","author":"Beutner","year":"1998","journal-title":"Clin. Infect Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/09546630903164891","article-title":"Treatment of recalcitrant periungual warts with cimetidine in pediatrics","volume":"21","author":"Chern","year":"2010","journal-title":"J. Dermatol. Treat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0190-9622(09)80278-8","article-title":"Cimetidine therapy for multiple viral warts in children","volume":"28","author":"Orlow","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2230.2000.00608.x","article-title":"Treatment of viral warts with cimetidine: An open-label study","volume":"25","author":"Gooptu","year":"2000","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0190-9622(97)80150-8","article-title":"Cimetidine therapy for warts in children","volume":"37","author":"Fischer","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0190-9622(96)90351-5","article-title":"Cimetidine therapy for multiple viral warts in children","volume":"35","author":"Bauman","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0190-9622(99)70421-4","article-title":"Cimetidine therapy for recalcitrant warts in adults: Is it any better than placebo?","volume":"41","author":"Rogers","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0190-9622(96)90279-0","article-title":"Cimetidine therapy for warts: A placebo-controlled, double blind study","volume":"34","author":"Yilmaz","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D387V1Z7HT","article-title":"Treatment of molluscum contagiosum: A brief review and discussion of a case successfully treated with adapalene","volume":"13","author":"Scheinfeld","year":"2007","journal-title":"Dermatol. Online J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3121\/cmr.4.4.273","article-title":"An Armamentarium of Wart Treatments","volume":"4","author":"Lipke","year":"2006","journal-title":"Clin. Med. Res."},{"key":"ref_16","first-page":"445","article-title":"Cimetidine treatment for viral warts enhances IL-2 and IFN-\u03b3 expression but not IL-18 expression in lesional skin","volume":"13","author":"Mitsuishi","year":"2003","journal-title":"Eur. J. Dermatol."},{"key":"ref_17","first-page":"547","article-title":"Immunomodulating activity of cimetidine in Iraqi children and adolescents with common warts","volume":"11","author":"Alsutany","year":"2014","journal-title":"Med. J. Babylon"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/1547691X.2012.708365","article-title":"Cimetidine enhances delayed-type hypersensitivity responses and serum interleukin (IL)-2, -10, -12, and IL-17 levels after burn injury in an animal model","volume":"10","author":"Jafarzadeh","year":"2013","journal-title":"J. Immunotoxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.4049\/jimmunol.161.5.2586","article-title":"Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors","volume":"161","author":"Elenkov","year":"1998","journal-title":"J. Immunol."},{"key":"ref_20","first-page":"242","article-title":"Histamine type-2 receptor antagonist immune modulation. II. Cimetidine and ranitidine increase interleukin-2 production","volume":"102","author":"Gifford","year":"1987","journal-title":"Surgery"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1468-3083.2001.03408.x","article-title":"Ranitidine therapy for recalcitrant warts in adults: A preliminary study","volume":"15","author":"Karaman","year":"2001","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaad.2010.12.050","article-title":"Human papillomavirus-related genital disease in the immunocompromised host: Part II","volume":"66","author":"Gormley","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_23","unstructured":"(2018, March 02). Cimetidine (Tagamet)\u00ae: Product Information from GlaxoSmithKline Australia Pvt Ltd., Most Recent Amendment 12 March 2008. Available online: https:\/\/pdfs.semanticscholar.org\/19d3\/c2e3873f5bded43a1e7c6e0abc69c7d63a48.pdf."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1517\/14740338.2012.712109","article-title":"Drug-induced gynecomastia: An evidence-based review","volume":"11","author":"Deepinder","year":"2012","journal-title":"Expert Opin. Drug Saf."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/6\/2\/30\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:59:58Z","timestamp":1760194798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/6\/2\/30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,8]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["medsci6020030"],"URL":"https:\/\/doi.org\/10.3390\/medsci6020030","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,8]]}}}